Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05754580 · ClinicalTrials.gov registry record · NA

High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

A NA study of Prostatic Cancer, sponsored by University of Nebraska.

Recruiting
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT05754580 is a NA study of Prostatic Cancer that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 53 participants, below the 2,990-participant average among 4 other Prostatic Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05754580, a NA study of Prostatic Cancer, is actively recruiting participants, sponsored by University of Nebraska.

RECRUITING
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

The objective of this phase I/II trial is to prospectively evaluate the toxicity and therapeutic efficacy of Stereostatic Body Radiation Therapy (SBRT) to prostate and pelvic lymph nodes in combination with high-dose-rate (HDR) brachytherapy to the prostate in patients with localized unfavorable-intermediate risk or higher disease.

Conditions Studied

Prostatic Cancer

Interventions

  • RADIATION High Dose Brachytherapy
  • RADIATION Stereostatic Body Radiation Therapy

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2023-08-29
Est. Completion 2027-10
Phase NA

Sponsor

University of Nebraska

407 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05754580

The ClinicalTrials.gov registry entry for NCT05754580 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,990-participant average among 4 other Prostatic Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostatic Cancer appearing as the primary indexed condition, and to 2 interventions - of which High Dose Brachytherapy is the first listed.

NCT05754580 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT05754580 about?

NCT05754580 is a clinical study titled "High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer". The objective of this phase I/II trial is to prospectively evaluate the toxicity and therapeutic efficacy of Stereostatic Body Radiation Therapy (SBRT) to prostate and pelvic lymph nodes in combination with high-dose-rate (HDR) brachytherapy to the prostate in patients with localized unfavorable-int...

What is the current status of trial NCT05754580?

This trial is currently recruiting. It is a NA study. The enrollment target is 53 participants. The study started on 2023-08-29. Estimated completion is 2027-10.

What conditions does trial NCT05754580 study?

This clinical trial studies the following conditions: Prostatic Cancer.

What interventions are being tested in trial NCT05754580?

The interventions under investigation include: High Dose Brachytherapy (RADIATION), Stereostatic Body Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT05754580?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05754580 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostatic Cancer

All registered trials for this condition

Nebraska

All trials with a study site in Nebraska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.